DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Cwm LLC

Cwm LLC increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 118.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,337 shares of the medical instruments supplier’s stock after acquiring an additional 3,975 shares during the quarter. Cwm LLC’s holdings in DENTSPLY SIRONA were worth $199,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. First Eagle Investment Management LLC raised its position in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after purchasing an additional 3,283,965 shares during the last quarter. SG Americas Securities LLC grew its holdings in shares of DENTSPLY SIRONA by 2,959.1% during the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after buying an additional 1,328,525 shares during the last quarter. Dimensional Fund Advisors LP increased its position in DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after acquiring an additional 1,308,411 shares during the period. Cooke & Bieler LP raised its stake in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after acquiring an additional 1,046,105 shares during the last quarter. Finally, Edmond DE Rothschild Holding S.A. lifted its position in DENTSPLY SIRONA by 398.2% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 1,025,200 shares of the medical instruments supplier’s stock worth $34,026,000 after acquiring an additional 819,400 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

XRAY has been the subject of several analyst reports. Robert W. Baird cut their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Needham & Company LLC restated a “buy” rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Finally, Stifel Nicolaus reduced their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $33.22.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $24.28 on Wednesday. The stock has a fifty day moving average price of $25.30 and a 200 day moving average price of $26.61. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The stock has a market cap of $4.92 billion, a PE ratio of -28.23, a P/E/G ratio of 1.19 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. During the same quarter in the prior year, the firm earned $0.51 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 4.3% on a year-over-year basis. Sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date was Friday, September 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -74.42%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.